Loading...
Pharmaceutical-grade research compounds
Our weight loss research category features GLP-1 receptor agonists — the most significant class of metabolic peptides discovered in the past two decades. These compounds target the glucagon-like peptide-1 receptor pathway, which plays a central role in glucose homeostasis, appetite regulation, and energy metabolism. Researchers worldwide are using these tools to study obesity, insulin resistance, and metabolic syndrome.
GLP-1 receptor agonists mimic the incretin hormone GLP-1, which is naturally released after eating. They slow gastric emptying, enhance insulin secretion, suppress glucagon, and act on hypothalamic appetite centers — providing multiple mechanisms for metabolic research.
Semaglutide is the most potent GLP-1 agonist currently available for research. Its modified amino acid sequence and fatty acid side chain give it an extended half-life of approximately 7 days, enabling once-weekly dosing protocols in research settings.
Tirzepatide represents the next generation: a dual GIP/GLP-1 receptor agonist. By targeting both incretin pathways simultaneously, it produces more pronounced metabolic effects than GLP-1 mono-agonists in preclinical models.
GLP-1 agonists are essential tools for studying glucose-dependent insulin secretion, beta-cell preservation, central appetite regulation, and cardiovascular protection mechanisms in metabolic disease models.
Semaglutide is a pure GLP-1 receptor agonist, while Tirzepatide is a dual GIP/GLP-1 receptor agonist. Tirzepatide targets two incretin pathways simultaneously, which research suggests may produce stronger metabolic effects.
GLP-1 agonists are supplied as lyophilized powder. Reconstitute with bacteriostatic water by slowly dispensing along the vial wall. Never shake — gently swirl until dissolved. Store reconstituted solution at 2-8°C.
All GLP-1 agonists are independently HPLC verified at ≥99% purity with mass spectrometry confirmation. Full Certificate of Analysis included with every order.
Showing 1–3 of 3 products
Dual GIP/GLP-1 receptor agonist — the most advanced compound in metabolic peptide research. Independently verified 99.1% purity.
HGH Fragment 176-191 — a key research peptide for studying lipolytic pathways without growth-promoting effects.
Premium GLP-1 receptor agonist for advanced metabolic research. Pharmaceutical-grade lyophilized powder with verified 99.2% purity.